Epiminder Ltd
EPI
Company Profile
Business description
Epiminder Ltd is a medical device and information solutions company focused on developing diagnostic and treatment tools for epilepsy. Its system is a sub-scalp device for continuous monitoring of electrographic brain activity and a set of information solutions, providing patients and their healthcare professionals with detailed data over an extended period.
Contact
525 Collins Street
210 West Podium, Mezzanine 2
MelbourneVIC3000
AUST: +61 452521634
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
30 June 2026
Employees
Stocks News & Analysis
stocks
Ahead of earnings, is Nvidia a buy, a sell, or fairly valued?
Amid robust demand for semis, watch for any impact of in-house built chips and whether the supply chain is on track.
stocks
Higher interest rates boost earnings for ASX real estate platform
Interest rates are driving a spike in property listings.
stocks
After earnings, is Palantir a buy, a sell, or fairly valued?
With uncertainty regarding its total addressable market and competitive threats, here’s what we think of Palantir stock.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,880.70 | 7.70 | 0.09% |
| CAC 40 | 8,006.14 | 26.22 | 0.33% |
| DAX 40 | 24,140.37 | 185.44 | 0.77% |
| Dow JONES (US) | 49,523.72 | 236.84 | -0.48% |
| FTSE 100 | 10,304.38 | 39.06 | 0.38% |
| HKSE | 26,388.44 | 40.53 | 0.15% |
| NASDAQ | 26,238.91 | 150.71 | 0.58% |
| Nikkei 225 | 63,272.11 | 529.54 | 0.84% |
| NZX 50 Index | 13,063.06 | 17.27 | -0.13% |
| S&P 500 | 7,411.11 | 10.15 | 0.14% |
| S&P/ASX 200 | 8,630.40 | 0.60 | -0.01% |
| SSE Composite Index | 4,242.57 | 28.08 | 0.67% |